STK-012 is an α/β biased IL-2 partial agonist designed to stimulate antigen-activated T cells while avoiding IL-2 associated toxicities Positive Phase 1b data recently presented at SITC 2025, with a ...
The Maricopa Association of Governments is studying one of the Valley's worst traffic bottlenecks at the Loop 101 and Loop 202 interchange. This interchange, where Tempe, Mesa, and Scottsdale meet, ...
What is the work? The Maricopa Association of Governments is conducting a study to find a solution to what engineers considered one of the worst bottlenecks in the county: the area around the ...
EMERYVILLE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...
Hosted on MSN
Alto Neuroscience’s ALTO-101 Study: A Potential Game-Changer for Schizophrenia Treatment?
Alto Neuroscience, Inc. ((ANRO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Aardvark Therapeutics, Inc. ((AARD)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert ...
Federal contracting offers businesses a unique path to stability, growth and purpose by partnering with one of the world’s largest and most reliable clients—the U.S. government. Each year, billions of ...
TEMPE, AZ (AZFamily) — A major traffic study is underway for one of the East Valley’s busiest freeway intersections, and officials want your input on potential solutions. The Maricopa County ...
Cisco warned customers today to patch two zero-day vulnerabilities that are actively being exploited in attacks and impact the company's firewall software. The first one (CVE-2025-20333) allows ...
There are multiple different types of drugs available for the treatment of Alzheimer’s disease: cholinesterase inhibitors to treat symptoms from mild to severe, and disease-modifying immunotherapies ...
Large network scans have been targeting Cisco ASA devices, prompting warnings from cybersecurity researchers that it could indicate an upcoming flaw in the products. GreyNoise has recorded two ...
1. In pretreated patients with nucleophosmin 1-mutated (NPM1m) acute myeloid leukemia (AML), nearly half of patients treated with revumenib showed a clinically meaningful response with an overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback